Table 1.
Baseline characteristics of subjects with and without DM
| All (n = 456) | Without DM (n = 334) | With DM (n = 122) | p | |
|---|---|---|---|---|
| Age (years) |
64 ± 14 |
64 ± 15 |
66 ± 12 |
0.15 |
| Men, n (%) |
261 (57) |
182 (54) |
79 (65) |
0.04 |
| Body mass index (kg/m2) |
23 ± 4 |
23 ± 3 |
25 ± 4 |
<0.01 |
| Waist circumference (cm) |
84 ± 11 |
82 ± 10 |
88 ± 11 |
<0.01 |
| Subcutaneous adipose tissue (cm2) |
136 ± 79 |
132 ± 76 |
147 ± 84 |
0.08 |
| Visceral adipose tissue (cm2) |
95 ± 55 |
88 ± 52 |
116 ± 58 |
<0.01 |
| Hypertension, n (%) |
263 (58) |
176 (53) |
87 (71) |
<0.01 |
| Dyslipidemia, n (%) |
208 (46) |
130 (39) |
78 (66) |
<0.01 |
| Current smoking, n (%) |
98 (21) |
72 (22) |
26 (21) |
0.96 |
| Total cholesterol (mg/dl) |
187 ± 37 |
188 ± 38 |
187 ± 36 |
0.95 |
| Triglycerides (mg/dl) |
143 (88) |
138 (107) |
154 (121) |
0.02 |
| HDL-cholesterol (mg/dl) |
57 ± 16 |
58 ± 16 |
56 ± 17 |
0.16 |
| LDL-cholesterol (mg/dl) |
111 ± 32 |
111 ± 33 |
110 ± 30 |
0.93 |
| Hemoglobin A1c (%) |
6.2 ± 1.2 |
5.7 ± 0.4 |
7.4 ± 1.6 |
<0.01 |
| High sensitivity CRP (mg/dl) |
0.16 (0.08) |
0.15 (0.08) |
0.17 (0.09) |
0.30 |
| Medications |
|
|
|
|
| Antihypertensive agents, n (%) |
239 (52) |
160 (48) |
79 (65) |
<0.01 |
| Lipid lowering agents n (%) |
138 (30) |
84 (25) |
54 (44) |
<0.01 |
| Hypoglycemic agents, n (%) | 82 (18) | 0 (0) | 82 (67) | <0.01 |
DM, diabetes mellitus; HDL, high-density lipoprotein; LDL, low-density lipoprotein; CRP, C-reactive protein.